{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:45:02Z","timestamp":1792511102891,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.carrev.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T10:13:11Z","timestamp":1749377591000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparative outcomes of clopidogrel vs aspirin monotherapy in post-PCI patients: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Shariq Ahmad","family":"Wani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abdullah","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bazil","family":"Azeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahila","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivaram","family":"Neppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.carrev.2025.06.006_bb0005","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1161\/CIRCULATIONAHA.114.013279","article-title":"Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents?","volume":"131","author":"Brener","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.06.006_bb0010","doi-asserted-by":"crossref","unstructured":"\u201cDual antiplatelet therapy: optimal timing, management, and duration | European Heart Journal - Cardiovascular Pharmacotherapy | Oxford Academic.\u201d Accessed: May 02, 2025. [Online]. Available: https:\/\/academic.oup.com\/ehjcvp\/article\/1\/3\/198\/389786","DOI":"10.1093\/ehjcvp\/pvv015"},{"key":"10.1016\/j.carrev.2025.06.006_bb0015","unstructured":"\u201cClopidogrel Outperforms Aspirin Monotherapy Following PCI,\u201d American College of Cardiology. Accessed: May 02, 2025. [Online]. Available: https:\/\/www.acc.org\/About-ACC\/Press-Releases\/2025\/03\/30\/15\/43\/http%3a%2f%2fwww.acc.org%2fAbout-ACC%2fPress-Releases%2f2025%2f03%2f30%2f15%2f43%2fClopidogrel-Outperforms-Aspirin-Monotherapy"},{"issue":"10293","key":"10.1016\/j.carrev.2025.06.006_bb0020","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet Lond Engl"},{"issue":"10486","key":"10.1016\/j.carrev.2025.06.006_bb0025","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(25)00449-0","article-title":"Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial","volume":"405","author":"Choi","year":"2025","journal-title":"Lancet"},{"issue":"47","key":"10.1016\/j.carrev.2025.06.006_bb0030","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1093\/eurheartj\/ehae617","article-title":"Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial","volume":"45","author":"Watanabe","year":"2024","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.carrev.2025.06.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101174","article-title":"Clopidogrel vs aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and Meta-analysis","volume":"48","author":"Tan","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.carrev.2025.06.006_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40360-024-00796-w","article-title":"A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation","volume":"25","author":"Lan","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.carrev.2025.06.006_bb0045","unstructured":"\u201cPRISMA statement,\u201d PRISMA statement. Accessed: May 02, 2025. [Online]. Available: https:\/\/www.prisma-statement.org"},{"issue":"5","key":"10.1016\/j.carrev.2025.06.006_bb0060","first-page":"459","article-title":"Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation","volume":"6","author":"Zhuang","year":"2014","journal-title":"J Thorac Dis"},{"issue":"9","key":"10.1016\/j.carrev.2025.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1253\/circj.CJ-20-0298","article-title":"Clopidogrel monotherapy vs. aspirin monotherapy following short-term dual antiplatelet therapy in patients receiving Everolimus-eluting coronary stent implantation","volume":"84","author":"Natsuaki","year":"2020","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents","volume":"9","author":"Park","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2025.06.006_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4070\/kcj.2019.0166","article-title":"Clopidogrel versus aspirin after dual antiplatelet therapy in acute myocardial infarction patients undergoing drug-eluting stenting","volume":"50","author":"Sim","year":"2020","journal-title":"Korean Circ J"},{"issue":"24","key":"10.1016\/j.carrev.2025.06.006_bb0085","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2025.06.006_bb0090","unstructured":"\u201c2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non\u2013ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery | Circulation.\u201d Accessed: May 02, 2025. [Online]. Available: https:\/\/www.ahajournals.org\/doi\/10.1161\/cir.0000000000000404"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.006_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892500291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892500291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:00:58Z","timestamp":1762570858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892500291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":16,"alternative-id":["S155383892500291X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative outcomes of clopidogrel vs aspirin monotherapy in post-PCI patients: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}